Loading organizations...
Loading organizations...
Drug discovery company developing treatments for alpha-1-antitrypsin defici
Z Factor has raised $9.1M across 1 funding round.
Z Factor has raised $9.1M in total across 1 funding round.
Z Factor has raised $9.1M in total across 1 funding round.
Z Factor's investors include David Grainger, Cambridge Enterprise, Cambridge Innovation Capital.
Z Factor has raised $9.1M across 1 funding round. Most recently, it raised $9.1M Series A in May 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 5, 2017 | $9.1M Series A | David Grainger | Cambridge Enterprise, Cambridge Innovation Capital |